The Director General of the World Intellectual Property Organization (WIPO) presents his compliments to the Minister for Foreign Affairs and has the honor to notify him of the receipt, on July 1, 2004, of the communication of the Kingdom of Belgium, dated June 28, 2004, regarding changes in the names and addresses, as well as in the texts concerning the kinds of microorganisms accepted for deposit, of the Belgian Coordinated Collections of Microorganisms (BCCMTM), an international depositary authority under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, done at Budapest on April 28, 1977, and amended on September 26, 1980 (see Budapest Notification No. 104 of February 12, 1992).
July 16, 2004
Text of the Communication by the Kingdom of Belgium Regarding Changes in the Names and Addresses, as well as in the Texts Concerning the Kinds of Microorganisms Accepted for Deposit, of the Belgian Coordinated Collections of Microorganisms (BCCMTM)
[Original: French]
COMMUNICATION
The data regarding the Belgian Coordinated Collections of Microorganisms (BCCMTM), institution for which the Government of Belgium made a declaration of assurances pursuant to Article 6(2) of the Budapest Treaty, have been verified and modified. Please find enclosed the final versions in French and in English.
The amendments mainly concern changes in the names and addresses of the Belgian institutions. Furthermore, in order to improve the legibility and avoid repetitions, the text of the chapter "List of Kinds of Microorganisms Accepted for Deposit" has been modified without affecting, however, the kinds of microorganisms accepted for deposit by the BCCMTM Collections under the Budapest Treaty.
The schedule of fees has not been amended.
The Government of Belgium continues to assure that the BCCM consortium carries out its function of international depositary authority under the best conditions.
ANNEX
BELGIUM
INTERNATIONAL DEPOSITARY AUTHORITY
Belgian Coordinated Collections of Microorganisms (BCCMTM)
Federal Public Planning Service Science Policy
8, rue de la Science
1000 Brussels
Telephone: (32-2) 238 34 11
Facsimile: (32-2) 230 59 12
E-mail: bosc@belspo.be
Internet: http://www.belspo.be/bccm/
COLLECTIONS
Institut scientifique de Santé publique
Section Mycologie (BCCMTM/IHEM)
14, rue J. Wytsman
1050 Brussels
Telephone: (32-2) 642 56 30
Facsimile: (32-2) 642 55 19
E-mail: bccm.ihem@iph.fgov.be
Universiteit Gent
Vakgroep Moleculaire Biologie - Plasmidecollectie (BCCMTM/LMBP)
Technologiepark 927
9052 Zwijnaarde
Telephone: (32-9) 331 38 43
Facsimile: (32-9) 331 35 04
E-mail: bccm.lmbp@dmbr.UGent.be
Universiteit Gent
Laboratorium voor Microbiologie - Bacteriëncollectie (BCCMTM/LMG)
K.L. Ledeganckstraat, 35
9000 Gent
Telephone: (32-9) 264 51 08
Facsimile: (32-9) 264 53 46
E-mail: bccm.lmg@UGent.be
Université catholique de Louvain
Mycothèque de l'Université catholique de Louvain (BCCMTM/MUCN( �br> Croix du Sud, 3 - bte 6
1348 Louvain-La-Neuve
Telephone: (32-10) 47 37 42
Facsimile: (32-10) 45 15 01
E-mail: bccm.mucl@mbla.ucl.ac.be
KINDS OF MICROORGANISMS THAT MAY BE DEPOSITED
BCCMTM/IHEM: filamentous fungi and yeasts, including pathogenic fungi and yeasts that cause mycosis in man and animals, and actinomycetes.
BCCMTM/LMBP: genetic material, recombinant or not, cloned in a host or in the form of isolated material (e.g. plasmids); natural or genetically modified human and animal cell lines, including hybridomas. Deposits of genetically modified microorganisms should belong to risk class 1 or 2 as defined by the European directive 98/81/EC concerning the contained use of genetically modified organisms.
BCCMTM/LMG: bacteria, including actinomycetes, but excepting pathogens belonging to a hazard group higher than Risk group 2 according to the EU directive 2000/54/EC.
BCCMTM/MUCL: filamentous fungi and yeasts, including phytopathogens, but excepting pathogenic fungi causing mycosis in man and animals belonging to a hazard group higher than Risk group 2 according to the EU directive 2000/54/EC.
As a general rule, the BCCMTM collections accept only strains that can be cultured under conditions technically feasible for the collection concerned and conserved, other than in continuous vegetative activity, without inducing significant changes in their characteristics.
Exceptionally, the various BCCMTM collections may accept deposits of microorganisms that cannot be conserved other than by active culture. Acceptance as well as the costs of such a deposit will be negotiated case by case with the potential depositor. Exceptionally and following the same case-by-case negotiation procedure, they may also accept deposits of mixtures of microorganisms provided that the composition of the mixture is defined and its components are identifiable (a mixture whose composition is not defined or whose components are non-identifiable will be automatically excluded).
The BCCMTM collections also reserve their right to refuse a deposit of biological material whose manipulation or conservation involves hazards deemed to be excessive.
All deposits should be addressed directly to the appropriate BCCMTM collection.
SCHEDULE OF FEES
1. | For cultures of bacteria, yeasts, filamentous fungi, including actinomycetes | EUR | |
(a) | Storage | 550 | |
(b) | Issuance of a viability statement: | ||
- when a viability test is carried out | 50 | ||
- based on the last viability test | 20 | ||
(c) | Furnishing of a sample | 50 | |
(d) | Communication of information | 20 | |
(e) | Issuance of an attestation | 20 | |
2. | For human cells, animal cells and hybridomas | ||
(a) | Storage | 1,200 | |
(b) | Issuance of a viability statement: | ||
- when a viability test is carried out | 75 | ||
- based on the last viability test | 20 | ||
(c) | Furnishing of a sample | 100 | |
(d) | Communication of information | 20 | |
(e) | Issuance of an attestation | 20 |
3. For genetic material (for example plasmids)
For genetic material that can be cryopreserved at -80°C, the schedule of fees for bacteria, yeasts and filamentous fungi is applicable (see paragraph 1, above). When genetic material requires storage in liquid nitrogen, the schedule of fees for human and animal cells is applicable (see paragraph 2, above).
Fees do not include the cost of transport or bank fees.